Substance / Medication

Ergometrine

Overview

Active Ingredient
ergonovine
RxNorm CUI
4021

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.
McDonald S, Abbott J M, Higgins S P · Cochrane Database Syst Rev · 2004
PMID: 14973949Meta-AnalysisFull text (PMC)
Efficacy of methylergometrine during the early puerperium: a randomized double-blind placebo-controlled clinical trial.
Sparice Stefania, Giampaolino Pierluigi, Sansone Anna et al. · J Matern Fetal Neonatal Med · 2020
PMID: 30257588RCT
[Effects of methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section].
Kikutani Takehiko, Kikutani Mariko, Oshima Masayuki et al. · Masui · 2006
PMID: 16715913RCT
Effects of maternal parity on response of human myometrium to oxytocin and ergometrine in vitro.
Ryan Gillian A, Crankshaw Denis J, Morrison John J · Eur J Obstet Gynecol Reprod Biol · 2019
PMID: 31580965Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ergometrine (substance)
SNOMED CT
126071000
UMLS CUI
C0014704
RxNorm CUI
4021

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.